Eli Lilly and Company (LLY)
| Previous close | 737.20 |
| Open | 775.00 |
| Bid | 779.11 x 1200 |
| Ask | 780.00 x 1100 |
| Day's range | 768.10 - 795.50 |
| 52-week range | 399.26 - 800.78 |
| Volume | |
| Avg. volume | 3,065,737 |
| Market cap | 738.327B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 133.43 |
| EPS (TTM) | 5.82 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | 5.20 (0.71%) |
| Ex-dividend date | 14 Feb 2024 |
| 1y target est | 826.94 |
- Yahoo Finance Video
Eli Lilly's GLP-1 demand drives up stock price post-Q1 results
Shares of Eli Lilly (LLY) are soaring in Tuesday's trading session after the company raised its full-year guidance, driven by the surging demand for its offerings. BMO Capital Markets BioPharma Equity Research Managing Director Evan Seigerman joins the Morning Brief to discuss the stock's outlook. Seigerman notes that "demand is off the charts" for the company, and the raised guidance supports the bullish outlook. Despite missing on revenue, the company beat profit expectations, bolstering Seigerman's optimism about the stock's future performance. Addressing the competitive landscape Seigerman says it's "unlikely that any competitors are going to be out there in the next couple of years." Even if competitors enter the market, he believes Eli Lilly will continue advancing, giving them a distinct advantage. Seigerman highlights that the company is becoming "more and more efficient," opening additional facilities to support the surging demand. However, he notes that demand is through the roof, making it challenging to keep up. The analyst adds that his price target for the company is $900, but the stock's performance will be "driven by how quickly they can ramp up supply because the demand is there." For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith
Investor's Business DailyStocks Retreat With Dow Hit Hardest; Tesla Drops As Executives Get Sacked
The Dow Jones was hit hardest of the major indexes in the stock market today. Eli Lilly soared while Tesla stock retreated after a big gain.
- Reuters
US STOCKS-Wall St falls in lead up to Fed verdict after hot labor costs data
Wall Street's main indexes fell on Tuesday with caution prevailing ahead of the Federal Reserve's interest-rate decision and as stronger-than-expected labor costs hinted at persistent inflation. U.S. labor costs increased in the first quarter amid a rise in wages and benefits, confirming the surge in inflation early in the year that will likely delay a much-anticipated interest rate cut later in 2024. "This pretty much tells you that the Fed is going to be very reluctant to reduce short-term interest rates in 2024 and that's had the predictable impact on the stock market," said Hugh Johnson, chief economist at Hugh Johnson Economics.
